Prevalence of BRCA1 and BRCA2 Mutations Among Patients With Ovarian, Primary Peritoneal, and Fallopian Tube Cancer in India: A Multicenter Cross-Sectional Study.
Sudeep GuptaSenthil RajappaSuresh AdvaniAmit AgarwalShyam AggarwalChanchal GoswamiSatya Dattatreya PalankiDevavrat AryaShekhar PatilRohit KodagaliPublished in: JCO global oncology (2021)
There is a high prevalence of pathogenic or likely pathogenic germline BRCA mutations in Indian patients with ovarian cancer.